After Initially Rejecting Patent, Indian Patent Office Grants Gilead Sciences Patent on Base Compound of Sofosbuvir Hepatitis C Drug
[Médecins Sans Frontières, Link] Gilead Sciences has been seeking patents in India for the hepatitis C drug sofosbuvir. The patent applications have been challenged by groups of people living with hepatitis C and HIV through ‘pre-grant oppositions.’ The patent just…